Utrecht Institute for Pharmaceutical Sciences
14
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
43%
6 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Immune-supportive Diet and Gut Permeability in Allergic Children
Role: collaborator
Study to Examine the Effect of the Diuretic Furosemide on the Plasma Levels of Toxins and the Removal of Toxins from the Blood in Patients with Chronic Kidney Disease
Role: collaborator
EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin
Role: lead
Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving
Role: lead
EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
Role: lead
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon
Role: lead
Naturalistic Study Into the Hangover Effects of MDMA
Role: lead
Energy Drinks & Driving Ability
Role: lead
A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment
Role: lead
Calibration and Validation of the STISIM Driving Simulator
Role: lead
Seasonal Allergic Rhinitis and Driving Ability
Role: lead
Effects of Alcohol on Simulated Driving
Role: lead
Effects of Ramelteon on Driving Ability
Role: lead
Methylphenidate and Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
Role: lead
All 14 trials loaded